000 01130 a2200325 4500
005 20250513211055.0
264 0 _c20000531
008 200005s 0 0 eng d
022 _a0364-5134
040 _aNLM
_beng
_cNLM
100 1 _ade Seze, J
245 0 0 _aEffect of glatiramer acetate (Copaxone) given orally in human patients: interleukin-10 production during a phase 1 trial.
_h[electronic resource]
260 _bAnnals of neurology
_cMay 2000
300 _a686 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Letter; Randomized Controlled Trial
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aAdministration, Oral
650 0 4 _aCytokines
_xbiosynthesis
650 0 4 _aDouble-Blind Method
650 0 4 _aGlatiramer Acetate
650 0 4 _aHumans
650 0 4 _aInterleukin-10
_xbiosynthesis
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aPeptides
_xpharmacology
700 1 _aEdan, G
700 1 _aLabalette, M
700 1 _aDessaint, J P
700 1 _aVermersch, P
773 0 _tAnnals of neurology
_gvol. 47
_gno. 5
_gp. 686
999 _c10757227
_d10757227